1 article
Scientists report that an AI-designed protein demonstrated up to 53% stronger anti-inflammatory activity in animal studies. The engineered IL-1 receptor antagonist variant was designed to bind more tightly to the IL-1 receptor and block inflammatory signaling more effectively than the current biologic therapy.
We use cookies to improve your experience on our site and to show you relevant advertising. To find our more, read our privacy policy and cookie policy